Ana Mingorance, PhD
Loulou Foundation

Ana Mingorance, PhD, is the Chief Development Officer of the Loulou Foundation, focused on accelerating the development of therapeutics for CDKL5 deficiency disorder. Ana is a specialist in genetic epilepsy syndromes and orphan drug development, and a strong advocate for patient involvement in drug discovery and development.